868368--12/26/2006--ROCHESTER_MEDICAL

related topics

{property, intellectual, protect}

{customer, product, revenue}

{product, liability, claim}

{product, market, service}

{control, financial, internal}

{regulation, change, law}

{personnel, key, retain}

{operation, international, foreign}

{capital, credit, financial}

We depend on private label sales arrangements and third party distributors for a significant portion of our revenues, the loss of one or more of which could reduce our future sales revenue Our products may not succeed in the market We may not succeed in establishing a separate brand identity for our Rochester Medical brand products We face significant competition in the market for urinary continence products Our products may become obsolete if we are unable to anticipate and adapt to new treatments or techniques We have a limited history of profitability and may experience future losses Our products and manufacturing activities are subject to extensive governmental regulation that could prevent us from selling our products or introducing new and/or improved products in the United States or internationally Our success may depend on the ability of healthcare providers to achieve adequate levels of third-party reimbursement We depend on certain key personnel, the loss of whom could harm our business We depend on a few suppliers for key components, making us vulnerable to supply shortages and price fluctuation All of our manufacturing operations are conducted at a single industrial park; therefore, any disruption at our existing facilities could substantially affect our business We depend on patents and proprietary rights, which we may not be able to protect We may face intellectual property infringement claims that would be costly to resolve We may face product liability claims that could result in costly litigation and significant liabilities International operations will expose us to additional risks We will incur significant increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance requirements We may be unable to meet our future capital requirements

Full 10-K form ▸

868368--12/26/2006--ROCHESTER_MEDICAL_CORPORATION